Evidence map›Paper›PMID 42587742›Full record

ReviewCells2026

Musculoskeletal Manifestations of T-Cell Lymphomas: Clinical Presentation, Imaging Features, Pathobiology, and Orthopedic Considerations-A Narrative Review.

Ibrahim Alshaygy, Abdulaziz S AlNahari, Mohannad W Awwad, Badr Fadhel Alshehri, Hayfaa Saud Alshaalan, Waleed Albishi, Motaz Alaqeel, Abdulrahman Alaseem

Abstract readReview
In one paragraph

Review in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ibrahim AlshaygyDepartment of Orthopedic Surgery, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.ORCID 0000-0001-6676-8803
Abdulaziz S AlNahariCollege of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.ORCID 0009-0008-4861-733X
Mohannad W AwwadCollege of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.ORCID 0000-0002-4594-6591
Badr Fadhel AlshehriDepartment of Orthopedic Surgery, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.
Hayfaa Saud AlshaalanDepartment of Orthopedic Surgery, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.
Waleed AlbishiDepartment of Orthopedic Surgery, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.
Motaz AlaqeelDepartment of Orthopedic Surgery, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.ORCID 0000-0001-8906-8367
Abdulrahman AlaseemDepartment of Orthopedic Surgery, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.ORCID 0000-0001-6034-9739

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphomas are a heterogeneous group of aggressive lymphoid malignancies characterized by frequent extranodal involvement. Musculoskeletal manifestations, although uncommon, represent a clinically significant and under-recognized presentation that often mimics primary bone tumors, soft tissue sarcomas, and infectious conditions, leading to diagnostic delays and inappropriate initial management. This narrative review synthesizes current evidence on the clinical presentation, imaging characteristics, pathology, and biological basis of musculoskeletal T-cell lymphomas, with particular emphasis on implications for orthopedic practice. A structured literature search was conducted across major databases from 2000 to the present, and evidence was integrated across clinical, radiologic, pathologic, and therapeutic domains. Musculoskeletal involvement most commonly presents with localized bone pain, soft tissue masses, or pathological fractures, with imaging features such as diffuse marrow infiltration, soft tissue extension, and relatively preserved cortical bone serving as important diagnostic clues. Definitive diagnosis relies on tissue biopsy with comprehensive immunophenotypic and molecular characterization. Emerging insights into the tumor microenvironment highlight its role in disease progression and therapeutic response, offering potential avenues for targeted treatment strategies. Management is subtype-specific and centers on systemic therapy, with selective roles for radiotherapy and orthopedic intervention in cases of structural compromise. Early recognition through integrated clinical, imaging, and pathological assessment, combined with multidisciplinary collaboration, is essential to optimize outcomes in this rare but challenging disease entity.

Indexed as

Lymphoma, T-CellMusculoskeletal DiseasesHumansbone lymphomaextranodal lymphomalymphoma imagingmusculoskeletal lymphomaorthopedic oncologypathological fractureperipheral T-cell lymphomasoft tissue massT-cell lymphomatumor microenvironment

Identifiers

PMID42587742
PMCPMC13465474

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.